FROST PHILLIP MD ET AL bought COCP

October 28, 2025 · Form 4 insider transaction

FROST PHILLIP MD ET AL bought 719,426 shares of Cocrystal Pharma, Inc. at $1.39 per share, a transaction worth $1.00M. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.

Direction
Acquired (buy-side)
Shares
719,426
Price
$1.39
Total value
$1.00M
RoleOfficer, Director, 10% owner
SecurityWarrants
Transaction codeA: Grant or award
Transaction dateOctober 28, 2025
Filing dateOctober 30, 2025
Shares owned after719,426
OwnershipIndirect
10b5-1 planNo
AmendedNo

Footnotes

The Reporting Person purchased units at $1.39 per unit with each unit consisting of one share of common stock and a warrant to purchase two shares of common stock. The shares of common stock and warrants purchased are exempt from Section 16(b) of the Securities Exchange Act of 1934 by virtue of Rule 16b-3 thereunder, as it was approved by a Special Committee of the Board of Directors of the Issuer, which Special Committee consisted of two non-employee directors. The warrants were exercisable upon issuance.; These shares are held by Frost Gamma Investments Trust, of which Phillip Frost M.D., is the trustee. Frost Gamma L.P. is the sole and exclusive beneficiary of Frost Gamma Investments Trust. Dr. Frost is one of two limited partners of Frost Gamma L.P. The general partner of Frost Gamma L.P. is Frost Gamma, Inc., and the sole stockholder of Frost Gamma, Inc. is Frost-Nevada Corporation. Dr. Frost is the sole stockholder of Frost-Nevada Corporation. The Reporting Person disclaims beneficial ownership of the securities held by Frost Gamma Investments Trust except to the extent of any pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

View the original Form 4 on SEC EDGAR
FROST PHILLIP MD ET AL bought COCP: October 28, 2025 | Insider Trading Screener